跳至主要内容
临床试验/NCT05518760
NCT05518760招募中不适用

A Multicenter Study to Assess the Effectiveness of an Inactivated COVID-19 Vaccine Against Hospitalized COVID-19

University of the Philippines1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2022年11月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
3,000
试验地点
1
主要终点
Number of hospitalized virologically-confirmed SARS-CoV-2 infection

研究概览

简要总结

This is a multi-site, observational, prospective test negative design case-control study which primarily aims to determine the protective effectiveness of 2 doses of an inactivated COVID-19 vaccine at least 14 days after the second dose, against hospitalized virologically-confirmed SARS-CoV-2 infection.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed consent.
  • Aged 18 years of age and above
  • Residing in the catchment area of the participating hospital
  • Admitted to the participating hospital with an acute respiratory illness
  • Able and willing to provide a naso- and oro-pharyngeal swab for RT-PCR testing

排除标准

  • 6.2.2.1 Refusal to participate

结局指标

主要结局

Number of hospitalized virologically-confirmed SARS-CoV-2 infection

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验